DUBAI, UAE, September 3rd, 2022 – MSD (tradename of Merck & Co., Inc., Rahway, N.J., USA (NYSE: MRK)), a leading biotechnology company, was honored today by the Emirates Oncology
Category: Business News
1,300 trials covering more than 30 tumor types
DUBAI, UAE, September 3rd, 2022 – MSD (tradename of Merck & Co., Inc., Rahway, N.J., USA (NYSE: MRK)), a leading biotechnology company, was honored today by the Emirates Oncology
